Central adrenal insufficiency in young adults with Prader-Willi Syndrome

Clinical Endocrinology

Volumn 79, Issue 3, 2013, Pages 371-378

  Grugni, Graziano ^a   Beccaria, Luciano ^b   Corrias, Andrea ^c   Crinò, Antonino ^d   Cappa, Marco ^d   De Medici, Clotilde ^a   Di Candia, Stefania ^e   Gargantini, Luigi ^f   Ragusa, Letizia ^g   Salvatoni, Alessandro ^h   Sartorio, Alessandro ^a   Spera, Sabrina ^d   Andrulli, Simeone ^b   Chiumello, Giuseppe ^e   Mussa, Alessandro ^c  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b A MANZONI HOSPITAL   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f Civic Hospital of Treviglio   (Italy)

^g OASI RESEARCH INSTITUTE IRCCS   (Italy)

^h UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE;

ADRENAL INSUFFICIENCY; ADULT; ARTICLE; CENTRAL ADRENAL INSUFFICIENCY; CHROMOSOME 15; CLINICAL ASSESSMENT; DIAGNOSTIC TEST; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HIGH DOSE SHORT SYNACHTEN TEST; HUMAN; LOW DOSE SHORT SYNACTHEN TEST; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; PHENOTYPE; PRADER WILLI SYNDROME; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

EID: 84880802959     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12150     Document Type: Article

References (39)

1. Bittel, D.C., &, Butler, M.G., (2005) Prader-Willi syndrome. Clinical genetics, cytogenetics and molecular biology. Expert Reviews in Molecular Medicine, 7, 1-20.
2. Cassidy, S.B., &, Driscoll, D.J., (2009) Prader-Willi syndrome. European Journal of Human Genetics, 17, 3-13.
3. Brambilla, P., Crinò, A., Bedogni, G., et al,. (2011) Metabolic syndrome in children with Prader-Willi syndrome: the effect of obesity. Nutrition, Metabolism & Cardiovascular Diseases, 21, 269-276.
4. Goldstone, A.P., (2004) Prader-Willi syndrome: advances in genetics, pathophysiology and treatment. Trends in Endocrinology & Metabolism, 15, 12-20.
5. Stevenson, D.A., Anaya, T.M., Clayton-Simth, J., et al,. (2004) Unexpected death and critical illness in Prader-Willi syndrome: report of ten individuals. American Journal of Medical Genetics Part A, 124A, 158-164.
6. Whittington, J.E., Holland, A.J., Webb, T., et al,. (2001) Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. Journal of Medical Genetics, 38, 792-798.
7. Schrander-Stumpel, C.T., Curfs, L.M., &, Sastrowijoto, P., (2004) Prader-Willi syndrome: causes of death in an international series of 27 cases. American Journal of Medical Genetics Part A, 124, 333-338.
8. Smith, A., Loughnan, G., &, Steinbeck, K., (2003) Death in adults with Prader-Willi syndrome may be correlated with maternal uniparental disomy. Journal of Medical Genetics, 40, e63.
9. Tauber, M., Diene, G., Molinas, C., et al,. (2008) A review of 64 cases of death in children with Prader-Willi syndrome (PWS). American Journal of Medical Genetics Part A, 46, 881-887.
10. Einfeld, S.L., Kavanagh, S.J., Smith, A., et al,. (2006) Mortality in Prader-Willi syndrome. American Journal on Mental Retardation, 111, 193-198.
11. Grugni, G., Crinò, A., &, Bosio, L., (2008) The Italian National Survey for Prader-Willi syndrome: an epidemiologic study. American Journal of Medical Genetics Part A, 146, 861-872.
12. Goldstone, A.P., Holland, A.J., &, Hauffa, B.P., (2008) Recommendations for the diagnosis and management of Prader-Willi syndrome. The Journal of Clinical Endocrinology & Metabolism, 93, 4183-4197.
13. Burman, P., Ritzen, E.M., &, Lindgren, A.C., (2001) Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocrine Reviews, 22, 787-799.
14. Iughetti, L., Bosio, L., Corrias, A., et al,. (2008) Pituitary height and neuroradiological alterations in patients with Prader-Labhart-Willi syndrome. European Journal of Pediatrics, 167, 701-702.
15. Miller, L., Angulo, M., Price, D., et al,. (1996) MR of the pituitary in patients with Prader-Willi syndrome: size determination and imaging findings. Pediatric Radiology, 26, 43-47.
16. Swaab, D.F., Purba, J.S., &, Hofman, M.A., (1995) Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. The Journal of Clinical Endocrinology & Metabolism, 80, 573-579.
17. Rudd, B.T., Chance, G.W., &, Theodoridis, C.G., (1969) Adrenal response to ACTH in patients with Prader-Willi syndrome, simple obesity, and constitutional dwarfism. Archives of Disease in Childhood, 44, 244-247.
18. Connell, N.A., Paterson, W.F., Wallace, A.M., et al,. (2010) Adrenal function and mortality in children and adolescents with Prader-Willi syndrome attending a single centre from 1991-2009. Clinical Endocrinology, 73, 686-688.
19. de Lind van Wijngaarden, R.F.A., Otten, B.J., Festen, D.A.M., et al,. (2008) High prevalence of central adrenal insufficiency in patients with Prader-Willi syndrome. The Journal of Clinical Endocrinology & Metabolism, 93, 1649-1654.
20. Nyunt, O., Cotterill, A.M., Archbold, S.M., et al,. (2010) Normal cortisol response on low-dose synacthen (1 μg) test in children with Prader Willi syndrome. The Journal of Clinical Endocrinology & Metabolism, 95, E464-467.
21. Farholt, S., Sode-Carlsen, R., Christiansen, J.S., et al,. (2010) Normal cortisol response to high dose synachten and insulin tolerance test in children and adults with Prader-Willi syndrome. The Journal of Clinical Endocrinology & Metabolism, 96, E173-180.
22. Wallace, I., Cunningham, S., &, Lindsay, J., (2009) The diagnosis and investigation of adrenal insufficiency in adults. Annals of Clinical Biochemistry, 46, 351-367.
23. Corrias, A., Grugni, G., Crinò, A., et al,. (2012) Assessment of central adrenal insufficiency in children and adolescents with Prader-Willi syndrome. Clinical Endocrinology, 76, 843-850.
24. de Lind van Wijngaarden, R.F., Joosten, K.F., van den Berg, S., et al,. (2009) The relationship between central adrenal insufficiency and sleep-related breathing disorders in children with Prader-Willi syndrome. The Journal of Clinical Endocrinology & Metabolism, 94, 2387-2393.
25. Kazlauskaite, R., Evans, A.T., Villabona, C.V., et al,. (2008) Corticotropin tests for hypothalamic-pituitary-adrenal insufficiency: a meta-analysis. The Journal of Clinical Endocrinology & Metabolism, 93, 4245-4253.
26. Holm, V.A., Cassidy, S.B., Butler, M.G., et al,. (1965) Prader-Willi syndrome: consensus Diagnostic Criteria. Pediatrics, 91, 398-402.
27. Tanner, J.M., Whitehouse, R.H., &, Takaishi, M., (1965) Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. Archives of Disease in Childhood, 41, 613-35.
28. Zarkovic, M., Ciric, J., Stojanovic, M., et al,. (1999) Optimizing the diagnostic criteria for standard (250-microg) and low dose (1-microg) adrenocorticotropin tests in the assessment of adrenal function. The Journal of Clinical Endocrinology & Metabolism, 84, 3170-3173.
29. Kazlauskaite, R., &, Maghnie, M., (2010) Pitfalls in the diagnosis of central adrenal insufficiency in children. Endocrine Development, 17, 96-107.
30. Dickstein, G., (2001) Hypothalamo-pituitary-adrenal axis testing: nothing is sacred and caution in interpretation is needed. Clinical Endocrinology, 54, 15-16.
31. Dickstein, G., (2003) The assessment of the hypothalamic-pituitary- adrenal axis in pituitary disease: are there short cuts? Journal of Endocrinological Investigation, 26, 25-30.
32. Ambrosi, B., Barbetta, L., Re, T., et al,. (1998) The one microgram adrenocorticotropin test in the assessment of hypothalamic-pituitary-adrenal function. European Journal of Endocrinology, 139, 575-579.
33. Ambrosi, B., &, Barbetta, L., (1999) The role of the low dose ACTH test in the evaluation of central hypoadrenalism. Journal of Endocrinological Investigation, 22, 492-495.
34. Abdu, T.A.M., Elhadd, T.A., Neary, R., et al,. (1999) Comparison of the low dose Short Synachten Test (1 μg), the conventional dose Short Synachten Test (250 μg), and the Insulin Tolerance Test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. The Journal of Clinical Endocrinology & Metabolism, 84, 838-843.
35. Tordjman, K., Jaffe, A., Trostanetsky, Y., et al,. (2000) Low-dose (1 μg adrenocorticotrophin (ACTH) stimulation as a screening test for impaired hypothalamic-pituitary-adrenal axis function: sensitivity, specificity and accuracy in comparison with the high-dose (250 μg) test. Clinical Endocrinology, 52, 633-640.
36. Maghnie, M., Uga, E., Temporini, F., et al,. (2005) Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycaemia, low-dose ACTH, standard ACTH and CRH stimulation tests. European Journal of Endocrinology, 152, 735-741.
37. Forssman, H., &, Hagberg, B., (1964) Prader-Willi syndrome in boy of ten with prediabetes. Acta Paediatrica, 53, 70-78.
38. Butler, M.G., Brandau, D.T., Theodoro, M., et al,. (2009) Cortisol levels in Prader-Willi syndrome support changes in routine care. American Journal of Medical Genetics Part A, 149A, 138-139.
39. Barbara, D.W., Hannon, J.D., &, Hartman, W.R., (2012) Intraoperative adrenal insufficiency in a patient with prader-willi syndrome. Journal of Clinical Medicine Research, 4, 346-348.